Back to results
US 10,501,437 B2Granted
Crystalline forms of N-[2-(3-Hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
AssigneeBayer Pharma Aktiengesellschaft
InventorsTobias Thaler, Johannes Platzek, Nicolas Guimond
Life of this patent
Estimating the term…
Abstract
The present invention relates to crystalline forms of N-[2-(3-Hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide, to processes for their preparation, to pharmaceutical compositions comprising them and to their use in the control of disorders.
Claims12
A hydrate of the compound of formula (I)
- wherein the hydrate has a X-ray powder diffraction diagram at 25° C. and with Cu-K alpha 1 as radiation source displaying at least the following reflections, quoted as 2Theta value ±0.2°:
- 9.4, 10.8, and 15.0.
Dependencies are inferred from the claim text.